NPPA and infection: Our data underscore the necessity to formulate vaccines against proteinaceous (non-capsular) Kp antigens, which, by expanding the population of memory-resident TH17 lymphocytes in the mucosal districts, also guarantee an optimal adaptive response to infections by antibiotic-resistant strains.